Allotment of equity shares by Morepen RX Limited, wholly owned subsidiary of the company

Date: 06/08/2026 National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East), Mumbai- 400 051 Dalal Street, Mumbai- 400 001 Symbol: MOREPENLAB Scrip Code: 500288 Subject: Intimation w.r.t., allotment of equity shares by Morepen RX Limited, wholly owned subsidiary, to the company Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) Dear Sir/ Madam, Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform you that Morepen RX Limited (‘MRX’), a wholly owned subsidiary of the company, has informed that its Board of Director of MRX at their meeting held today i.e., 6th August 2026, has allotted 2,00,00,000 (Two Crore) equity shares of Rs. 10/- (Rupees Ten Only) each, at par, aggregating to Rs. 20,00,00,000/- (Rupees Twenty Crores Only), to the company pursuant to its rights issue. Further, the Finance Committee of the Board of Directors of the company, at its meeting held today, has, inter alia, taken note aforesaid allotment. Consequent to aforesaid allotment, the company’s shareholding in MRX has increased to 2,70,82,356 (Two Crore Seventy Lakh Eighty-Two Thousand Three Hundred Fifty-Six) equity shares. The MRX continues to remain a wholly owned subsidiary of the company. The details as required under the SEBI Listing Regulations read with SEBI master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026, is given in the Annexure. Please take note of the above. Thanking you, Yours faithfully, For Morepen Laboratories Limited Vipul Kumar Srivastava Company Secretary F-12148 Encl.: a/a. Morepen Laboratories Limited CIN NO. L24231 HP1984PLC006028 Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector-20, Gurugram, Haryana-122016, INDIA TEL.: +91 124 4892000, E-mail: corporate@morepen.com, Website: www.morepen.com Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA Tel.: +91 1795 266401-03, 244590, Fax: +91 1795 244591, E-mail: plants@morepen.com Annexure Disclosure in terms of Regulation 30 read with SEBI master Circular No. HO/49/14/14(7)2025-CFD POD2/I/3762/2026 dated 30th January 2026 Sr. no. Particulars Details 1. Name of the target entity, details in Morepen RX Limited (MRX), a wholly brief such as size, turnover etc. owned subsidiary of the company; MRX had a turnover of Rs. 5,449.84 Lakh and a net worth of Rs. 47.72 Lakh based on the audited financial statements for the financial year ended 31st March 2026. 2. Whether the acquisition would fall Yes, MRX is a wholly owned subsidiary and within related party transaction(s) and a related party of the company. whether the promoter/ promoter group/ group companies have any interest in Mr. Sanjay Suri, Mr. Varun Suri and Ms. the entity being acquired? Shalu Suri members of promoter group of the company are also the Directors of MRX. If yes, nature of interest and details thereof and whether the same is done at Except as stated above, none of the “arm’s length” promoter(s), promoter group or group companies has any other interest in MRX. 3. Industry to which the entity being Pharmaceutical acquired belongs 4. Objects and impact of acquisition Subscription to the rights issue of MRX to (including but not limited to, disclosure strengthen its capital base and support its of reasons for acquisition of target business operations. entity, if its business is outside the main line of business of the listed entity) 5. Brief details of any governmental or Not applicable regulatory approvals required for the acquisition 6. Indicative time period for completion of Not applicable the acquisition 7. Consideration - whether cash Cash consideration or share swap or any other form and details of the same. 8. Cost of acquisition and/or the price at 2,00,00,000 (Two Crore) equity shares of which the shares are acquired Rs. 10/- each, at par, to cost is Rs. 20,00,00,000/- (Rupees Twenty Crores Only). Morepen Laboratories Limited CIN NO. L24231 HP1984PLC006028 Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector-20, Gurugram, Haryana-122016, INDIA TEL.: +91 124 4892000, E-mail: corporate@morepen.com, Website: www.morepen.com Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA Tel.: +91 1795 266401-03, 244590, Fax: +91 1795 244591, E-mail: plants@morepen.com 9. Percentage of shareholding / control 2,00,00,000 (Two Crore) equity shares of acquired and / or number of shares Rs. 10/- each, at par, in the rights issue of acquired MRX. The company continues to hold 100% of the equity share capital of MRX. 10. Brief background about the entity MRX was incorporated on 17th March 2023, acquired in terms of products/line of and is engaged the business of sales and business acquired, date of marketing of Branded Prescription ("Rx") incorporation, history of last 3 years’ products. It primarily operates in India. The turnover, country in which the acquired history of turnover is as under: entity has presence and any other significant information (in brief) Financial Year Turnover (Rs. in/lakh) 2025-26 5,449.84 2024-25 11,276.35 2023-24 8,383.45 Morepen Laboratories Limited CIN NO. L24231 HP1984PLC006028 Corp. Off.: 2nd Floor, Tower C, DLF Cyber Park, Udyog Vihar-III, Sector-20, Gurugram, Haryana-122016, INDIA TEL.: +91 124 4892000, E-mail: corporate@morepen.com, Website: www.morepen.com Regd. Off.: Morepen Village, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) -173205, INDIA Tel.: +91 1795 266401-03, 244590, Fax: +91 1795 244591, E-mail: plants@morepen.com